Adeza to Present at the Roth Capital Partners New York Conference
31 Agosto 2005 - 3:00AM
Business Wire
Adeza (NASDAQ: ADZA) today announced that Emory V. Anderson,
president and chief executive officer, will make an investment
community presentation at the Roth Capital Partners New York
Conference on Wednesday, September 7 at 3:30 p.m. Eastern Time
(12:30 p.m. Pacific Time). The conference is being held at the
Westin New York at Times Square. A live audio and slide webcast of
the presentation will be available via the Internet by visiting the
Investors section of the company's Web site at www.adeza.com. An
archived presentation will be available on the Web site for 14
days. About Adeza Adeza designs, manufactures and markets
innovative products for women's health. Adeza's initial focus is on
reproductive healthcare, using its proprietary technologies to
predict preterm birth and assess infertility. Adeza's principal
product is a patented diagnostic test, FullTerm(TM) The Fetal
Fibronectin Test, which utilizes a single-use, disposable cassette
and is analyzed on Adeza's patented TLiIQ(R) System. This product
is approved by the U.S. Food and Drug Administration (FDA) for
broad use in assessing the risk of preterm birth. Adeza also
markets and sells the E-tegrity(R) Test, an infertility-related
test to assess receptivity of the uterus to embryo implantation in
women with unexplained infertility. More information is available
at www.adeza.com. Adeza cautions you that statements included in
this press release that are not a description of historical facts
may be forward-looking statements. The inclusion of forward-looking
statements should not be regarded as a representation by Adeza that
any of its plans will be achieved. Actual results may differ
materially from those set forth in this release due to the risks
and uncertainties inherent in Adeza's business including, without
limitation, statements about the expansion of the indications for
its products. All forward-looking statements are qualified in their
entirety by this cautionary statement and Adeza undertakes no
obligation to revise or update this news release to reflect events
or circumstances after the date hereof.
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Adeza (NASDAQ:ADZA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Adeza Biomedical (MM) (NASDAQ): 0 recent articles
Más de Adeza Artículos de Noticias